PHILADELPHIA, June 15, 2026 (GLOBE NEWSWIRE) — Early-stage investing is in a reset. After years of flowing capital, investors and entrepreneurs face a different reality: longer liquidity timelines, fewer checks, and heightened scrutiny. The old model of broad exposure and rapid funding has given way to a more selective, disciplined approach where only the most prepared companies move forward.
In Philly, Keiretsu Forum-MST, is helping redefine how early-stage companies move from ideas to investment. Working alongside institutions like West Chester University’s Cottrell Entrepreneurship Center to identify, develop, and prepare companies for investor scrutiny.
In April, two companies, at very different stages, emerge out of this model, illustrating how it’s working.
Quix Labs: From Ecosystem Engagement to National Investor Stage
Quix Labs, led by CEO Zachary Starr, started the company at 16 years old after watching friends become addicted to vaping, prompting him to develop a solution to help users gradually reduce nicotine consumption.
While working within West Chester University’s Cottrell Entrepreneurship Center, Starr refined the company through ongoing engagement with the university and exposure to Keiretsu Forum-MST, gaining critical insight into investor expectations and company readiness.
Just weeks ago, Quix Labs was selected to present at the Angel Capital Association’s Innovation Funders Showcase, where the company is now in active discussions with multiple investors and progressing through diligence.
“I started Quix Labs after seeing how quickly people my age were getting addicted to vaping,” said Zachary Starr, CEO of Quix Labs. “Keiretsu helped us understand how investors evaluate risk, structure, and execution, and that’s what opened the door to opportunities like ACA.”
Acute Baby Co.: Building with Discipline Before Capital
At an earlier stage, Acute Baby Co. founded by CEO Wendy Barbalinardo, represents the front end of the same ecosystem.
After struggling with the physical demands of breastfeeding firsthand, Barbalinardo founded Acute Baby Co. with a mission to improve the feeding experience for mothers and babies through more customizable and supportive postpartum products.
The company was named the 2026 winner of West Chester University’s Big Idea Pitch Competition and also received Keiretsu Forum-MST’s Chuck Carter IdeaXcellence Award, which includes $5,000 in non-dilutive funding and mentorship from the angel network. The recognition comes with a clear expectation: when the company is ready to raise institutional capital, it will enter the Keiretsu pipeline.
Barbalinardo has taken a deliberate approach, bootstrapping development, validating the product, and preparing the business before pursuing outside investment.
“I’ve been intentional about building this the right way to ensure the product is market ready before bringing in outside capital,” said Wendy Barbalinardo, founder of Acute Baby Co. “Opportunities like at West Chester University and Keiretsu Forum-MST give you exposure to how investors think, but they also reinforce how important timing is and the risk of raising too early.”
Why This Matters Now
This structure reflects a broader shift in early-stage investing.
According to Keiretsu Forum-MST leadership, success in this environment requires discipline, governance, and execution.
“The market has changed. Capital is more selective, timelines are longer, and investors are no longer funding potential alone; they’re funding preparedness,” said Howard Lubert, President of Keiretsu Forum-MST. “What we’re building is a system that identifies companies early, helps them develop with discipline, and brings them forward when they’re truly ready for capital and accountability.”
The Responsibility of the Ecosystem
What makes this model work:
- Universities provide early exposure, education, and experimentation
- Investor networks apply structured diligence and real-world expectations
- Syndication to National platforms validate companies at scale
Keiretsu Forum-MST operates at the heart of this model, engaging early, but investing selectively, and focusing on companies that meet defined criteria for execution and potential outcomes.
As early-stage investing becomes more selective, the advantage is shifting toward founders and investors who operate within structured ecosystems.
Quix Labs shows what happens when a company reaches investor readiness. Acute Baby Co. shows how that journey begins.
Their example points to the fact that early-stage investing will not be defined by access to capital but by the systems that prepare companies to earn it.
About Keiretsu Forum-MST
Keiretsu Forum-MST is an investor-led community focused on curated deal flow, structured diligence, and disciplined early-stage investing. As part of the global Keiretsu Forum network, it connects accredited investors with rigorously screened companies and supports active investor participation throughout the investment lifecycle.
Media Contact:
Cindi Sutera
Keiretsu Forum-MST Communications
cindis@amscommunications.net
610-613-2773
